Stay updated on Padsevonil for Drug-Resistant Epilepsy Clinical Trial

Sign up to get notified when there's something new on the Padsevonil for Drug-Resistant Epilepsy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Padsevonil for Drug-Resistant Epilepsy Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page’s footer software/version indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a platform release with no apparent change to the study details.
    Difference
    0.0%
    Check dated 2026-04-24T05:44:26.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision: v3.5.2 is displayed on the page, replacing Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-17T02:13:22.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-18T21:09:51.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T17:44:27.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the government funding status notice and Revision: v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-11T02:50:04.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    Added a notification banner about potential processing delays due to a lapse in government funding and that the NIH Clinical Center is open. Updated the site revision from v3.4.0 to v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-04T01:00:46.000Z thumbnail image

Stay in the know with updates to Padsevonil for Drug-Resistant Epilepsy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Padsevonil for Drug-Resistant Epilepsy Clinical Trial page.